SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.

Howard, LM; Huang, X; Chen, W; Liu, Y; Edwards, KM; Griffin, MR; Zhu, Y; Vidal, JE; Klugman, KP; Gil, AI; et al. Howard, LM; Huang, X; Chen, W; Liu, Y; Edwards, KM; Griffin, MR; Zhu, Y; Vidal, JE; Klugman, KP; Gil, AI; Soper, NR; Thomsen, IP; Gould, K; Hinds, J; Lanata, CF; Grijalva, CG (2023) Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children. Int J Infect Dis, 134. pp. 248-255. ISSN 1878-3511 https://doi.org/10.1016/j.ijid.2023.07.007
SGUL Authors: Gould, Katherine Ann

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview
[img]
Preview
PDF (Supplementary materials) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (478kB) | Preview

Abstract

OBJECTIVES: We examined the association of nasopharyngeal (NP) pneumococcal co-colonization (>1 pneumococcal serotype) and pneumococcal density in young Peruvian children enrolled in a prospective cohort study. METHODS: NP swabs collected monthly from children aged <3 years during both asymptomatic and acute respiratory illness (ARI) periods underwent culture-enriched microarray for pneumococcal detection and serotyping and lytA polymerase chain reaction for density assessment. We examined the serotypes commonly associated with co-colonization and the distribution of densities by co-colonization, age, current ARI, and other covariates. The association of co-colonization and pneumococcal density was assessed using a multivariable mixed-effects linear regression model, accounting for repeated measures and relevant covariates. RESULTS: A total of 27 children contributed 575 monthly NP samples. Pneumococcus was detected in 302 of 575 (53%) samples, and co-colonization was detected in 61 of these 302 (20%). The total densities were higher during ARI than non-ARI periods and lowest among the youngest children, increasing with age. In the multivariable analysis, there was no significant association between pneumococcal density and co-colonization (coefficient estimate 0.22, 95% confidence interval 0.11-0.55; reference: single-serotype detections). Serotypes 23B and 19F were detected significantly more frequently as single isolates. CONCLUSION: Pneumococcal co-colonization was common and not associated with increased pneumococcal density. Differential propensity for co-colonization was observed among individual serotypes.

Item Type: Article
Additional Information: © 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: Pneumococcal colonization, Pneumococcal density, Streptococcus pneumoniae, Humans, Child, Infant, Streptococcus pneumoniae, Serogroup, Pneumococcal Infections, Prospective Studies, Peru, Nasopharynx, Pneumococcal Vaccines, Carrier State, Nasopharynx, Humans, Streptococcus pneumoniae, Pneumococcal Infections, Pneumococcal Vaccines, Prospective Studies, Carrier State, Child, Infant, Peru, Serogroup, Streptococcus pneumoniae, Pneumococcal density, Pneumococcal colonization, 0605 Microbiology, 1108 Medical Microbiology, 1117 Public Health and Health Services, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Int J Infect Dis
ISSN: 1878-3511
Language: eng
Dates:
DateEvent
20 July 2023Published
13 July 2023Published Online
9 July 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
UL1 RR024975-01Vanderbilt University Clincal and Translational Science AwardUNSPECIFIED
WS1898786Pfizerhttp://dx.doi.org/10.13039/100004319
WS2079099Pfizerhttp://dx.doi.org/10.13039/100004319
02832-9Thrasher Research Fundhttp://dx.doi.org/10.13039/100005627
1K23AI141621National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
PubMed ID: 37451394
Web of Science ID: WOS:001049371300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115771
Publisher's version: https://doi.org/10.1016/j.ijid.2023.07.007

Actions (login required)

Edit Item Edit Item